OSEO
Theradiag Receives $1.6M to Develop Test Kits for HIV/AIDS, Obesity Project
NEW YORK (GenomeWeb News) – Theradiag today announced that Oséo has provided it €1.2 million ($1.6 million) to develop new diagnostic kits as part the French firm's participation in a project to develop RNA-targeting therapeutics and diagnostics aimed at HIV/AIDS and obesity.
France Funds $17M Cancer Profiling, Biomarker Effort
NEW YORK (GenomeWeb News) – The French government has provided €13.4 million ($17.4 million) to fund the Innovative MODels Initiative (IMODI), a partnership aimed at facilitating the development of new cancer treatments.
Exonhit Granted $2.4M as Part of Project to Develop New Cancer Therapies, Companion Diagnostic
NEW YORK (GenomeWeb News) – Exonhit today said it has been awarded €1.9 million ($2.4 million) to participate in a project aimed at developing new treatments for cancers and tools to identify patients who may be best candidates for the treatments.
TcLand Expression Receives $1.7M to Validate Companion Dx for Rheumatoid Arthritis
The funding will be used primarily to set up a European multi-center clinical trial for the validation of a molecular test to predict non-response to anti-TNF treatment, in particular Remicade.
Protein Biomarkers for Alzheimer's Predicted to Represent Cumulative $9B Market Over Next Decade
Premium
The figure comes from a report commissioned by proteomics firm Proteome Sciences, which, like a number of other protein biomarker firms including Quanterix, Rules-Based Medicine, and NextGen Sciences, has made AD a significant focus of its R&D and commercialization efforts.